Mirtazapine Teva (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases norepinephrine release, and by antagonizing 5‑HT2 and 5‑HT3 serotonin receptors. These actions raise the levels of norepinephrine and serotonin in the brain, contributing to its antidepressant effect.

The appropriate dose of Mirtazapine Teva is determined by the prescribing clinician based on the individual’s clinical condition, response to therapy, and tolerability. Patients should follow the dosage instructions provided by their healthcare professional.

Safety of Mirtazapine Teva in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using this medication.

To order Mirtazapine Teva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapine differs from selective serotonin reuptake inhibitors (SSRIs) by its dual action on norepinephrine and serotonin pathways and its antihistaminic properties, which often cause sedation and weight gain. It may be preferred when patients experience insomnia or need an alternative to SSRIs, but individual response varies.

Mirtazapine Teva should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Mirtazapine Teva is taken orally, usually as a tablet. The tablet should be swallowed whole with water, preferably in the evening due to its sedative effect, unless otherwise directed by a healthcare professional.

Serious risks include agranulocytosis, severe neutropenia, seizures, hypersensitivity reactions such as rash or anaphylaxis, and the possible emergence or worsening of suicidal thoughts. Patients should seek immediate medical attention if they experience any of these severe symptoms.

Mirtazapine Teva is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients, and in those currently taking monoamine oxidase inhibitors (MAOIs). Caution is also advised for individuals with severe hepatic impairment, uncontrolled epilepsy, or a history of suicidal behavior.